Brown-Forman’s July 23, 2026 board meeting approved a regular quarterly cash dividend of US$0.2310 per share, extending an 82-year record of uninterrupted payouts and 42 years of dividend increases for both its Class A and Class B stock.
The announcement came soon after CEO and President Lawson Whiting disclosed plans to retire after nearly 30 years at Brown-Forman, placing leadership succession alongside dividend continuity at the center of investor attention.
We’ll now examine how Lawson Whiting’s planned retirement and the board’s reaffirmed dividend policy could influence Brown-Forman’s investment narrative.
Find 49 companies with promising cash flow potential yet trading below their fair value.
Brown-Forman Investment Narrative Recap
To own Brown-Forman, you need to believe its portfolio of spirits and longstanding dividend focus can offset category headwinds such as moderation, competition, and developed-market softness. The near term catalyst remains how the business executes through these consumption and margin pressures, while the biggest current risk is sustained weakness in core markets and evolving consumer preferences. The latest dividend reaffirmation and CEO retirement plan do not materially change that near term risk reward focus.
The most relevant announcement here is the board’s approval of a US$0.2310 quarterly dividend, extending 82 years of uninterrupted payouts and 42 years of increases. For investors watching slowing earnings and a challenging fiscal 2026, that decision highlights the board’s priority on returning cash even as succession planning and category headwinds play out, and it sits alongside earlier M&A approaches and discussions that had already pushed governance and long term positioning into sharper focus.
Yet against this long dividend record, investors should still weigh how rising health moderation trends and weaker developed markets could challenge Brown-Forman’s core brands and…
Read the full narrative on Brown-Forman (it’s free!)
Brown-Forman’s narrative projects $4.1 billion revenue and $811.1 million earnings by 2029. This implies 1.7% yearly revenue growth and about a $96 million earnings increase from $715.0 million today.
Uncover how Brown-Forman’s forecasts yield a $28.02 fair value, a 7% upside to its current price.
Exploring Other Perspectives 
BF.B 1-Year Stock Price Chart
While consensus expects modest progress, the most pessimistic analysts saw revenue stuck near US$3.9 billion and 2029 earnings at about US$728 million, reminding you that views on Brown-Forman’s risks and catalysts can differ sharply and may shift again as the CEO transition and dividend path evolve.
Explore 6 other fair value estimates on Brown-Forman – why the stock might be worth 23% less than the current price!
Reach Your Own Conclusion
Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.
Ready For A Different Approach?
Our daily scans reveal stocks with breakout potential. Don’t miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BF-B.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com